Patents by Inventor Anna Wojtowicz-Krawiec

Anna Wojtowicz-Krawiec has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, use of the insulin analogue, dosage method and method of treatment of diabetes
    Patent number: 9585942
    Abstract: The invention relates to an insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, application of the insulin analogue, dosage method and method of treatment of diabetes. In more detail, the solution pertains to compounds being stable insulin analogues which are pharmaceutically active and characterized by a prolonged, flat, truly peakless course of glucose concentration vs. time during repeated administration and which do not show strong 24 hours fluctuations of glucose concentration, or the so-called “sawteeth effect”, during this time. Results of studies of compounds included in the scope of this application indicate an improvement in the effects of diabetes treatment by avoiding the hitherto occurring adverse influence of changes in glucose concentration throughout the entire day on a patient's organism, e.g.
    Type: Grant
    Filed: May 22, 2013
    Date of Patent: March 7, 2017
    Assignee: Instytut Biotechnologii i Antybiotykow
    Inventors: Piotr Borowicz, Andrzej Płucienniczak, Jerzy Mikołajczyk, Jarosław Antosik, Jacek Pstrzoch, Justyna Bernat, Diana Mikiewicz-Syguła, Monika Bogiel, Dorota Stadnik, Graźyna Płucienniczak, Boźena Tejchman-Małecka, Tadeusz Głąbski, Iwona Sokołowska, Dariusz Kurzynoga, Anna Wojtowicz-Krawiec, Marcin Zieliński, Malgorzata Kęsik-Brodacka, Natalia Łukasiewicz, Violetta Cecuda-Adamczewska, Monika Pawłowska, Tomasz Pawlukowiec, Jacek Stępniewski
  • Insulin Analogue Or Its Pharmaceutically Acceptable Salt, Pharmaceutical Composition With Prolonged Therapeutic Effect, Use Of The Insulin Analogue, Dosage Method and Method of Treatment of Diabetes
    Publication number: 20150164998
    Abstract: The invention relates to an insulin analogue or its pharmaceutically acceptable salt, pharmaceutical composition with prolonged therapeutic effect, application of the insulin analogue, dosage method and method of treatment of diabetes. In more detail, the solution pertains to compounds being stable insulin analogues which are pharmaceutically active and characterised by a prolonged, flat, truly peakless course of glucose concentration vs. time during repeated administration and which do not show strong 24 hours fluctuations of glucose concentration, or the so-called “sawteeth effect”, during this time. Results of studies of compounds included in the scope of this application indicate an improvement in the effects of diabetes treatment by avoiding the hitherto occurring adverse influence of changes in glucose concentration throughout the entire day on a patient's organism, e.g.
    Type: Application
    Filed: May 22, 2013
    Publication date: June 18, 2015
    Applicant: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOW
    Inventors: Piotr Borowicz, Andrzej Plucienniczak, Jerzy Mikolajczyk, Jaroslaw Antosik, Jacek Pstrzoch, Justyna Bernat, Diana Mikiewicz-Sygula, Monika Bogiel, Dorota Stadnik, Grazyna Plucienniczak, Bozena Tejchman-Malecka, Tadeusz Glabski, Iwona Sokolowska, Dariusz Kurzynoga, Anna Wojtowicz-Krawiec, Marcin Zielinski, Malgorzata Kesik-Brodacka, Natalia Lukasiewicz
  • INSULIN ANALOGUES OF PROLONGED ACTIVITY
    Publication number: 20140121353
    Abstract: New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes.
    Type: Application
    Filed: November 26, 2013
    Publication date: May 1, 2014
    Applicant: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOW
    Inventors: Piotr BOROWICZ, Andrzej PLUCIENNICZAK, Jerzy MIKOLAJCZYK, Tadeusz GLABSKI, Dariusz KURZYNOGA, Diana MIKIEWICZ-SYGULA, Anna WOJTOWICZ-KRAWIEC, Marcin ZIELINSKI, Malgorzata KESIK-BRODACKA, Violetta ADAMCZEWSKA-CECUDA, Iwona SOKOLOWSKA, Grazyna PLUCIENNICZAK, Dorota STADNIK, Jaroslaw ANTOSIK, Jacek PSTRZOCH, Justyna BERNAT, Wojciech SLAWINSKI, Tomasz PAWLUKOWIEC, Jacek STEPNIEWSKI, Monika BOGIEL
  • Insulin analogues of prolonged activity
    Patent number: 8618048
    Abstract: New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes.
    Type: Grant
    Filed: July 4, 2009
    Date of Patent: December 31, 2013
    Assignee: Instytut Biotechnologii I Antybiotyków
    Inventors: Piotr Borowicz, Andrzej Plucienniczak, Jerzy Mikolajczyk, Tadeusz Glabski, Dariusz Kurzynoga, Diana Mikiewicz-Sygula, Anna Wojtowicz-Krawiec, Marcin Zielinski, Malgorzata Kesik-Brodacka, Violetta Adamczewska-Cecuda, Iwona Sokolowska, Grazyna Plucienniczak, Dorota Stadnik, Jaroslaw Antosik, Jacek Pstrzoch, Justyna Bernat, Wojciech Slawinski, Tomasz Pawlukowiec, Jacek Stepniewski, Monika Bogiel
  • NEW INSULIN ANALOGUES OF PROLONGED ACTIVITY
    Publication number: 20110136736
    Abstract: New biosynthetic analogues of recombined human insulin of prolonged therapeutical activity, which can find place in prophylactic and treatment of diabetes.
    Type: Application
    Filed: July 4, 2009
    Publication date: June 9, 2011
    Applicant: INSTYTUT BIOTECHNOLOGII I ANTYBIOTYKOW
    Inventors: Piotr Borowicz, Andrzej Plucienniczak, Jerzy Mikolajczyk, Tadeusz Glabski, Dariusz Kurzynoga, Diana Mikiewicz-Sygula, Anna Wojtowicz-Krawiec, Marcin Zieelinski, Malgorzata Kesik-Brodacka, Violetta Adamczewska-Cecuda, Iwona Sokolowska, Grazyna Plucienniczak, Dorota Stadnik, Jaroslaw Antosik, Jacek Pstrzoch, Justyna Bernat, Wojciech Slawinski, Tomasz Pawlukowiec, Jacek Stepniewski, Monika Bogiel